Unité de Fabrication des Médicaments S.A (BVMT:UMED)

BVMT:UMED Revenue

Unité de Fabrication des Médicaments S.A had revenue of 76.59M TND in the half year ending December 31, 2025, with 2.46% growth. This brings the company's total for the last twelve months to 141.61M, down -7.96% year-over-year. In the year 2025, Unité de Fabrication des Médicaments S.A had annual revenue of 148.91M with 0.84% growth. That makes Unité de Fabrication des Médicaments S.A the 28,378th largest company in the world by revenue and 40th in Tunisia.

• Revenue (ttm): 141.61M
• Revenue Growth: -7.96%
• P/S Ratio: 1.85
• Revenue / Employee: 247.57K
• Employees: 572
• Market Cap: 262.40M

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Tunisia 101.91M 68.4%
• Export 47.00M 31.6%

Fiscal year ended Dec 31, 2025 See the full BVMT:UMED breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	148.91M	1.24M	0.84%
Dec 31, 2024	147.68M	11.67M	8.58%
Dec 31, 2023	136.00M	39.64M	41.14%
Dec 31, 2022	96.36M	11.85M	14.02%
Dec 31, 2021	84.51M	-6.53M	-7.18%

Data Source: S&P Global Market Intelligence Last updated: May 20, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 24, 2026

Data Sources Report a data error